Ruqiya Anees
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruqiya Anees has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ihtisham Bukhari
Marshall B. J. Medical Research Center, Zhengzhou University, Henan, China
1 shared publication - Madeeha Shahzad Lodhi
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan
1 shared publication - Muhammad Inam
School of Medicine, Qilu Institute of Technology
1 shared publication - Muhammad Maisam
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, 1 km Defense Road, Lahore (58810), Pakistan
1 shared publication - Rana Ismail Anwar
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1 km Defence Road, Lahore, 58810, Pakistan
1 shared publication - Sumaira Sharif
Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan
1 shared publication
Latest Publications
- Open Access
- 22 October 2024
- Published by Society of Eminent Biological Scientists in International Journal of Applied and Experimental Biology
Biofabricated silver nanoparticles from Calotropis procera: A potential antimicrobial solution against pathogenic bacteria
Calotropis procera has the potential as a traditional medicinal plant that offers a diverse array of healing treatments. It was used in conventional medicine to remedy several ailments, including diarrhea and snakebites. This study examines the antibacterial properties of silver nanoparticles derived from the floral and latex components of C. procera. The nanoparticles were tested for their effectiveness against Gram-negative and Gram-positive bacterial strains. For characterization, the synthesized nanoparticles underwent thorough analysis using UV spectroscopy, fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM). After the reduction process, the FTIR analysis revealed that some functional biomolecules found in plants form a coating on the nanoparticles, serving as organic agents that stabilize the nanoparticles. The size of nanoparticles analyzed with SEM falls in the 30 to 130 nm range. Furthermore, the synthesized silver nanoparticles were tested as antimicrobial agents against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudomonas aeruginosa, well-known microorganisms that can produce ulceration phases and severe health consequences. After a comprehensive examination, it was found that the silver nanoparticles have significant antibacterial effectiveness, particularly against S. aureus, a primary bacterium responsible for causing different ailments. The remarkable antibacterial efficacy of the silver nanoparticles synthesized in an environment-friendly manner underscores its potential applications in combating the evolution of antibiotic-resistant strains.
- 22 October 2024
- Published by Society of Eminent Biological Scientists in International Journal of Applied and Experimental Biology
Open AccessBiofabricated silver nanoparticles from Calotropis procera: A potential antimicrobial solution against pathogenic bacteria
Calotropis procera has the potential as a traditional medicinal plant that offers a diverse array of healing treatments. It was used in conventional medicine to remedy several ailments, including diarrhea and snakebites. This study examines the antibacterial properties of silver nanoparticles derived from the floral and latex components of C. procera. The nanoparticles were tested for their effectiveness against Gram-negative and Gram-positive bacterial strains. For characterization, the synthesized nanoparticles underwent thorough analysis using UV spectroscopy, fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM). After the reduction process, the FTIR analysis revealed that some functional biomolecules found in plants form a coating on the nanoparticles, serving as organic agents that stabilize the nanoparticles. The size of nanoparticles analyzed with SEM falls in the 30 to 130 nm range. Furthermore, the synthesized silver nanoparticles were tested as antimicrobial agents against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudomonas aeruginosa, well-known microorganisms that can produce ulceration phases and severe health consequences. After a comprehensive examination, it was found that the silver nanoparticles have significant antibacterial effectiveness, particularly against S. aureus, a primary bacterium responsible for causing different ailments. The remarkable antibacterial efficacy of the silver nanoparticles synthesized in an environment-friendly manner underscores its potential applications in combating the evolution of antibiotic-resistant strains.